2. Signaling Pathways
  3. Anti-infection
  4. Bacterial

Bacterial

Bacterial

Related Products

PDF 14.26 MB

Anything that destroys bacteria or suppresses their growth or their ability to reproduce. Heat, chemicals such as chlorine, and antibiotic drugs all have antibacterial properties. Many antibacterial products for cleaning and handwashing are sold today. Such products do not reduce the risk for symptoms of viral infectious diseases in otherwise healthy persons. This does not preclude the potential contribution of antibacterial products to reducing symptoms of bacterial diseases in the home.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N14526
    Octacosamicin A
    		Inhibitor
    Octacosamicin A has the function of resisting bacterium, yeast, and filamentous fungus, but the function of resisting bacterium is weak.
    Octacosamicin A
  • HY-N3640
    Crenatine
    		Inhibitor
    Crenatine is an antibacterial agent. Crenatine is more effective against Gram-positive than Gram-negative bacteria.
    Crenatine
  • HY-14743R
    Golotimod (Standard)
    		Inhibitor
    Golotimod (Standard) is the analytical standard of Golotimod. This product is intended for research and analytical applications. Golotimod (SCV-07), an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of antituberculosis therapy, stimulates thymic and splenic cell proliferation, and improves macrophage function. Golotimod (SCV-07) inhibits STAT3 signaling and modulates the duration and severity of oral mucositis in animal models that received radiation or a combination of radiation and Cisplatin. Golotimod (SCV-07) is also a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2).
    Golotimod (Standard)
  • HY-N14653
    Glysperin A
    		Inhibitor
    Glysperin A has anti-Gram positive bacteria and negative bacteria (including aminoglycoside antibiotic resistant bacteria) activity.
    Glysperin A
  • HY-124508
    Lambertellin
    		Inhibitor
    Lambertellin is an effective antibiotic that can be used as a bactericide and as a fungicide. Lambertellin exerts its anti-inflammatory effect in LPS (HY-D1056)-stimulated RAW 264.7 macrophage cells by modulating the activation of the MAPK and NF-κB signaling pathways.
    Lambertellin
  • HY-169635
    Mycobacterium Tuberculosis-IN-6
    		Inhibitor
    Mycobacterium Tuberculosis-IN-6 (compound b1) is an inhibitor of Mycobacterium tuberculosis enoyl reductase InhA, with IC50 of 7.74 μM. Mycobacterium Tuberculosis-IN-6 can be used for antibacterial research.
    Mycobacterium Tuberculosis-IN-6
  • HY-N14881
    Monorden E
    		Inhibitor
    Monorden E has the effect of arresting the cell cycle of Jurket cells in G1 and G2/M phases. Monorden E has anti-Aspergillus niger activity.
    Monorden E
  • HY-N6043R
    Hydroxytyrosol acetate (Standard)
    		Inhibitor
    Hydroxytyrosol acetate (Standard) is a prodrug of Hydroxytyrosol (HY-N0570). Hydroxytyrosol acetate (Standard) is converted into the active form of Hydroxytyrosol in vivo. Hydroxytyrosol is a phenol found in the olive oil. Hydroxytyrosol can alleviate oxidative stress and improve mitochondrial function, thereby exerting neuroprotective effects. Hydroxytyrosol can induce cancer cells apoptosis via inducing ROS production. Hydroxytyrosol shows antibacterial and antiviral effect. Hydroxytyrosol can be used for the researches of cancer, infection, inflammation, immunology, metabolic, neurological and cardiovascular disease, such as colon cancer, diabetes, Alzheimer's Disease and atherosclerosis .
    Hydroxytyrosol acetate (Standard)
  • HY-15781R
    Morinidazole (Standard)
    		Inhibitor
    Morinidazole (Standard) is the analytical standard of Morinidazole. This product is intended for research and analytical applications. Morinidazole is an orally active and 5-nitroimidazole antimicrobial agent that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation. Morinidazole can be used for bacterial infections research including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria.
    Morinidazole (Standard)
  • HY-161065
    HKI12134085
    		Inhibitor
    HKI12134085 (compound 3) is an orally available antibacterial nitrobenzothiazinone (BTZ) derivative with activity against Mycobacterium tuberculosis. HKI12134085 has in vivo inhibitory potency in a BALB/c mouse model of Mycobacterium tuberculosis infection.
    HKI12134085
  • HY-Y0335R
    1,3-Dihydroxyacetone (Standard)
    		Inhibitor
    1,3-Dihydroxyacetone (Standard) is the analytical standard of 1,3-Dihydroxyacetone. This product is intended for research and analytical applications. 1,3-Dihydroxyacetone (DHA), the main active ingredient in sunless tanning skin-care preparations and an important precursor for the synthesis of various fine chemicals, is produced on an industrial scale by microbial fermentation of glycerol (HY-B1659) in Gluconobacter oxydans. 1,3-Dihydroxyacetone is also used for synthesis of new biodegradable polymers by combining with lactic acid (HY-B2227).
    1,3-Dihydroxyacetone (Standard)
  • HY-B0465R
    Oxacillin sodium monohydrate (Standard)
    		Inhibitor
    Oxacillin (sodium monohydrate) (Standard) is the analytical standard of Oxacillin (sodium monohydrate). This product is intended for research and analytical applications. Oxacillin sodium monohydrate is an antibiotic similar to Flucloxacillin used in resistant staphylococci infections study.
    Oxacillin sodium monohydrate (Standard)
  • HY-N14674
    Permetin A
    		Inhibitor
    Permetin A is a peptide antibiotic. Permetin A has anti-Gram-negative bacteria, Gram-positive bacteria and anaerobic bacteria activity.
    Permetin A
  • HY-N14750
    Emimycin
    		Inhibitor
    Emimycin has anti-Gram-positive bacteria, negative bacteria and brewer's yeast and other fungal activities.
    Emimycin
  • HY-175723
    MAO-A/B-IN-4
    		Inhibitor
    MAO-A/B-IN-4 is an orally active MAO-A/B inhibitor, with IC50 values of 51.3 μM and 47.0 μM, respectively. MAO-A/B-IN-4 exhibits potent activity against S. aureus, MSSA, MRSA, LRSA, and LREFa. MAO-A/B-IN-4 demonstrates potent antibacterial efficacy in a mouse model of LRSA peritonitis infection. MAO-A/B-IN-4 can be used for the study of bacterial infections.
    MAO-A/B-IN-4
  • HY-B1374S
    ent-Florfenicol-d3
    		Inhibitor
    ent-Florfenicol-d3 is the deuterium labeled Florfenicol. Florfenicol, a commonly used veterinary antibiotic, is currently indicated for the treatment of bovine respiratory disease, and also used in aquaculture for the control of enteric septicemia in catfish. Florfenicol can induce early embryonic death in eggs, with an LC50 of 1.07 μg/g.
    ent-Florfenicol-d<sub>3</sub>
  • HY-133975
    Isoleucylcysteine
    Isoleucylcysteine, a dipeptide composed of isoleucine and cysteine, is an intermediate peptide in bacitracin biosynthesis.
    Isoleucylcysteine
  • HY-113698
    L 652813
    		Inhibitor
    L 652813 is a quaternary ammonium heterocyclic amino β-lactam compound. L 652813 exhibits inhibitory activity against a broad spectrum of aerobic and anaerobic bacteria in vitro. L 652813 also exhibits good antibacterial activity in a mouse experimental bacteremia model.
    L 652813
  • HY-135117R
    Glyceryl monocaprate (Standard)
    		Inhibitor
    Glyceryl monocaprate (Standard) is the analytical standard of Glyceryl monocaprate. This product is intended for research and analytical applications. Glyceryl monocaprate (Monocaprin) is a 1-monoglyceride of capric acid against gram-positive bacterial infections. Glyceryl monocaprate (Monocaprin has inhibitory effect on Herpes Simplex Virus (HSV) and offers an effective treatment for herpes labialiss.
    Glyceryl monocaprate (Standard)
  • HY-B0024R
    Prulifloxacin (Standard)
    		Inhibitor
    Prulifloxacin (Standard) is the analytical standard of Prulifloxacin. This product is intended for research and analytical applications. Prulifloxacin (NM441) is an orally active fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and -negative bacteria. Prulifloxacin is a proagent of a thiazeto-quinoline carboxylic acid derivative Ulifloxacin (NM394). Prulifloxacin has the potential for lower urinary tract infections and exacerbations of chronic bronchitis.
    Prulifloxacin (Standard)
Cat. No. Product Name / Synonyms Application Reactivity